The subclinical form of visceral leishmaniasis (VL) 
disease (15.1%), and those with the subclinical form that is resolved after a prolonged period of time (44.2%). In most cases, the children were initially indistinguishable.
Professionals working in endemic AVL areas often face doubts about children with nonspecific symptoms and about the evolution and clinical behavior of the subclinical form of AVL and its diagnostic confirmation. Doubts also arise about whether suitable therapy should be instituted since the determinant factors of the evolution to disease are not established and because of the confusion with others causes of mild symptoms. Thus, the objective of the present study was to define the clinical and laboratory profile of the subclinical form of AVL.
PATIENTS AND METHODS
A cohort study was carried out in endemic areas of AVL, in the state of Maranhão, Brazil, between January/ 1998 and Dececember/2000.
Areas of investigation -The areas selected were Vila Nova and Vila Bom Viver (villages in the municipal district of Raposa, MA, Brazil - Fig. 1 ) known to be endemic for AVL, with an incidence of 3.3 cases/1000 inhabitants per year. The district is located 28 km from the state capital, São Luis. The Center for Tropical Pathology and Social Medicine, Federal University of Maranhão (UFMA) and the National Health Foundation (Funasa, MA) have been conducting studies in this area for 15 years with the objective of controlling the more common diseases (AVL and malaria). Chagas disease, mansonic schistosomiasis or American tegumentary leishmaniasis have not been reported in this area (Caldas et al. 2001) .
Study population -All 905 children aged 0-5 years, residents of Vila Nova and Vila Bom Viver, were assessed; however 784 children that respected regularly scheduled visits (every 45 days for 30 consecutive months) were studied. On the occasion of the first visit, ELISA using L.
(L.) chagasi antigen was carried out to discriminate between individuals infected or not to Leishmania. Regardless of the serological results, all children were clinically evaluated and submitted to regular monthly visits for the possible detection of nonspecific symptoms. The health agent of Funasa/MA, and the community health agents of the municipal district helped to locate the children. If the children presented any symptoms, the adults responsible for them and the agents were instructed to return immediately for clinical evaluation and laboratory analysis (blood count, protein count, blood sedimentation rate, and transaminases determination). The children with symptoms were evaluated every 3 days until they could be classified and complementary exams were requested if necessary.
Children were assembled into four different groups according to the clinical and laboratory initial manifestation and to their final clinical course. The symptoms considered were fever, diarrhea, cough, pallor, hepatomegaly and/or splenomegaly. 1) AVL acute form/Group 1-12 children (classic symptoms of AVL); 2) asymptomatic form/ Group 2-144 children (positive ELISA), oligosymptomatic or subclinical; 3) form/Group 3-33 children (two or more mild symptoms, with positive ELISA); and 4) children without AVL classification/Group 4-595 children (specific clinical situation, not classified as a clinical form of AVL). After the children were classified as oligosymptomatic or as having the acute form of the disease, specific tests for the diagnosis of AVL were done -ELISA with leishmanial antigen, again, and a bone marrow aspirate to search for Leishmania amastigotes forms. A single pediatrician performed all clinical evaluations.
The clinical data were recorded and analyzed utilizing the SPSS-PC program (Statistical Package for Social Sciences, PC version 10.0). First, the incidence of the all variables [fever, cough, diarrhea, pallor, hepatomegaly, splenomegaly, leukopenia, lymphocytosis, anemia, thrombocytopenia, hypoalbuminemia, hyperglobulinemia, increased blood sedimentation rate (BSR) and transaminases] was calculated for each group and compared among groups using analysis of variance (ANOVA) or the KruskalWallis test. A multiple discriminant analysis was performed to identify the combination of variables that would permit the discrimination between groups.
The study was approved by the Ethics Committees of the University of São Paulo and the Federal University of Maranhão and fulfilled the requirements of the Resolution of the National Council for Health 196/96 for research involving humans. . 2 shows the distribution of children into the four groups based on their final clinical course. After the children identification with positive or not ELISA (infected or not to Leishmania) it was proceeded its monthly followup. Along the clinical reevaluations, it was observed that 12 children who had developed to AVL acute form out of 4 presented positive ELISA previously and from 33 children classified with subclinical form only 8 of them presented an infection in the serum conspicuosness observed previously to the classification.
RESULTS

Fig
The incidence of the variables was calculated for each group and a comparative analysis of the data by ANOVA or the Kruskal-Wallis test showed that all variables differed significantly among the 4 groups, except cough (p = 0.630).
A multiple discriminant analysis (MDA) was performed to determine the combination of variables that characterized the subclinical form. Two functions were derived to distinguish the oligosymptomatic group from the others ( Table I ). The importance of each variable within each function is expressed by its correlation coefficient and its importance for the diagnosis of the subclinical form was compared with the other groups. To validate the multiple discriminant models, its functions were applied to the validation sample -these can represented 99.9% of the variations of the original measurement. Cross-validation showed that the model correctly classified 82% of the all cases.
The combination of fever, hepatomegaly, hyperglobulinemia, and increased BSR (function 1) distinguished the subclinical form from the asymptomatic cases and from children without AVL classification. MDA also showed that the combination of splenomegaly and leukopenia (function 2) distinguished the acute form from the subclinical cases. Therefore, when function 1 values are high, the subclinical form is more likely to be present, and when function 2 values are high, the acute form is more likely to be present. Fig. 3 shows the difficulty in dividing group 2 (asymptomatic) and group 4 (without AVL classification) into different clinical forms. The other variables contributed little to the statistical model.
For the subclinical form, the clinical and laboratory findings were variable and fever was the major complaint (Table II) . The duration of symptoms ranged from 10 to 40 days, with no intermittent course during follow-up. It is considered hepatomegaly and splenomegaly when the guts were felt below the flange joint in the back, and it was observed that the hepatomegaly varied from 3 to 5 cm, and the splenomegaly from 3 to 5 cm, however they were not present at all children. The associations of signs and symptoms were varied (Table III) . By the way, in the group with the acute form, there was always an association of four signs/symptoms -fever, hepatomegaly, splenomegaly, and pallor -in each individual. Table IV shows the clinical and laboratory differences between the oligosymptomatic cases with a negative or positive search of Leishmania in the bone marrow aspirate. The duration of symptoms and the dimensions of the visceromegalies did not differ between the two groups (p # 0.05).
DISCUSSION
No previous studies have been performed with monthly follow-up of children infected and not to Leishmania to discriminate between the subclinical or oligosymptomatic cases from the other frequent and possible diagnoses.
The present study confirmed that the oligosymptomatic form was more frequent than the acute form of AVL. However, in the literature, the subclinical form occurs in almost 60% of the infected subjects (Badaró et al. 1986 ) while in the present study it occurred in only 17.4%, probably because the other common causes of the mild symptomatology were evaluated and ruled out before the AVL classification. This means that, in an endemic area, the professionals must consider other usual diagnoses even in the presence of a reactive serological test. of the subclinical group with spontaneous resolution was 8 years.
In this cohort, prolonged or intermittent mild illness was not observed, in agreement with Evans et al. (1992) , who followed-up the infected subjects, although there are literature reports showing that the duration of symptoms is up to 35 months in the subclinical form (Badaró et al. 1986 ). Different epidemiological situations can determine different clinical behavior.
The spontaneous resolution of the subclinical form without progression to the acute form has been discussed since 1906, although many authors refer to the asymptomatic form as being synonymous of the subclinical form, a fact that impairs comparative analysis (Leishman 1906 apud Pampiglione 1974 , Guerra et al. 1985 , Holaday et al. 1993 , Shiddo et al. 1995 , D'Oliveira Jr et al. 1997 Using the multiple discriminant analysis, the interaction of the all variables was determined to define the subclinical form profile. It showed that two associations (functions 1 and 2) represented almost 100% of the cases. The combination of fever, hepatomegaly, hyperglobulinemia, and increased BSR (function 1) can predict the oligosymptomatic form, and therefore this function can be interpreted as "nonspecific clinical and laboratory manifestations related to AVL". The occurrence of splenomegaly and leukopenia (function 2) distinguished the acute form from the oligosymptomatic form and can therefore be interpreted as "specific manifestation of AVL disease" because it characterize the illness, occurring in almost 100% of the cases of acute form of AVL (Silva 1957 , Pastorino 1993 , WHO 1997 .
On the basis of these findings, in the present analysis the subclinical form was characterized as a peculiar and specific clinical form which differs from the other diagnoses with mild symptomatology and which is not an early stage of AVL disease (acute or classic forms). The subclinical cases (all children aged 5 years or less) did not progress to the acute form of AVL. In the study by Badaró et al. (1986) the mean age of the subclinical group progressing to disease was four years and the mean age It is important to observe the overlap of the groups of asymptomatic subjects and of subjects "without AVL" which emphasizes that, without a suggestive symptomatology, a positive search of anti-Leishmania antibodies does not indicate a parasitological investigation or specific treatment. In spite of the peculiar profile, in the oligosymptomatic form the bone marrow aspirate did not contribute to the characterization of the disease and thus would not be essential in daily practice.
In the present study, the symptomatology was variable but the literature also reports many variations. Pampiglione et al. (1974) reported infected children with discrete splenomegaly and hyperglobulinemia; Ho et al. (1982) reported 34 cases with splenomegaly (12 with associated fever and malaise). In a transverse study, Shiddo et al. (1995) reported 7 children infected to Leishmania with splenomegaly (two with diarrhea and cough). In the study performed in Jacobina/Bahia, the subclinical group with spontaneous resolution presented diarrhea (18.4%), cough (13.1%), fever (10.5%), hepatomegaly (97.4%), and splenomegaly (28.9%), with 27.3% of positivity in the bone marrow aspirate -some cases with leukopenia too (Badaró et al. 1986 ). These data are divergent, probably due to the different study models.
This study demonstrated that there was a wide diversity of the symptoms associated with the oligosymptomatic form, but the model of analysis proposed showed that, although mild and nonspecific, the clinical manifestations were of significant value to define the oligosymptomatic or subclinical form of AVL.
During the clinical analysis, the immunological markers for the oligosymptomatic or subclinical form of VL were identifying. This can be seen in Gama et al. (2004) .
